Alibaba Group Holding Ltd.’s ATH-Token Foundry, in collaboration with the Gaoling School of Artificial Intelligence at Renmin University of China, has open-sourced LOGOS, the first foundational AI model utilizing a unified scientific grammar to bridge multiple disparate scientific fields.
The model, whose name stands for Language of Generative Objects in Science, treats biological macromolecules and chemical compounds as text sequences. By mapping out proteins, small molecules, and material structures under a single generative framework, the system eliminates the traditional requirement for separate, specialized AI models for different scientific tasks. In benchmark testing across six representative scientific disciplines, the model matched or outperformed existing domain-specific software.
The open-source release highlights a stark shift in processing efficiency. The smaller variant, LOGOS-1B, features just one billion parameters but successfully outperformed Microsoft Corp.’s NatureLM, a mixture-of-experts model containing a far larger architecture, across several tasks. Alibaba built the platform using a pre-training corpus comprising 44.87 billion tokens, spanning seven distinct modalities. This data lake encompasses 28.9 billion tokens for proteins, 3 billion tokens for antibodies, 2.1 billion tokens for small molecules, and billions more covering chemical reactions, metal-organic frameworks, and protein-ligand interactions.
Traditionally, artificial intelligence systems require explicit three-dimensional coordinates and heavy geometric neural networks to understand how small molecules bind to proteins. The new Chinese model bypasses this computational hurdle by digitizing three-dimensional spatial contact patterns into discrete tokens. This linguistic approach allows the model to predict complex spatial interactions solely through sequential text processing, removing the need for physical coordinate inputs. By aligning the pre-training objectives with downstream generation tasks, the system can predict and design molecules out of the box without requiring the extensive and costly fine-tuning typical of older AI architectures.
The global release of an open-source, highly efficient scientific model carries immediate implications for multinational pharmaceutical companies, academic research labs, and the broader geopolitical competition over artificial intelligence infrastructure. By putting a lightweight yet powerful model into the public domain, Alibaba is lowering the financial and computational barriers to advanced biotech research, allowing smaller biotechnology firms and global research institutes to accelerate drug discovery pipelines without investing in massive supercomputing clusters.
From an industrial standpoint, the ability of a single model to translate the sequence of a protein pocket directly into a compatible small-molecule structure compresses the early-stage drug design process from months to days. This cross-modality knowledge sharing could fundamentally disrupt the global contract research organization sector, as automated molecular generation becomes more accessible.
The breakthrough underscores a narrowing gap between Chinese and American AI capabilities in the critical domain of AI for Science, often called AI4S. While Western tech giants like Google’s DeepMind and Microsoft have historically led the structural biology field with models like AlphaFold, Alibaba's sequence-based approach offers a highly efficient alternative that challenges the West's monopoly on advanced bio-informatic tools. As biological data increasingly becomes a arena for national security and technological sovereignty, the open-sourcing of LOGOS ensures that China remains a principal architect of the foundational digital tools shaping the future of global medicine and materials science.